<DOC>
	<DOCNO>NCT02851381</DOCNO>
	<brief_summary>Single compassionate use subject 83 year old woman history lymph node positive breast cancer recently diagnose pancreatic cancer May . With Eastern Cooperative Oncology Group ( ECOG ) 2 , felt tolerate aggressive chemotherapy . The investigator propose administer FG-3019 compassionate plea basis combination gemzar . The patient currently treat tolerate gemzar .</brief_summary>
	<brief_title>Compassionate Single Subject Use FG-3019 ( FibroGen ) Locally Advanced , Unresectable Pancreatic Cancer</brief_title>
	<detailed_description>The FG-3019 treatment administer 28-day cycle : - Dose : 35 mg/kg - Route : IV one hour follow completion gemcitabine infusion - Schedule : - Days 1 , 8 , 15 - Please note Day 8 infusion complete first treatment cycle On Drug Evaluation The patient see prior every FG-3019 treatment treat physician . The following procedure conduct visit : - History thorough symptom assessment - Physical examination - Laboratory assessment ( collect 3 day prior treatment ) : - Complete blood count ( CBC ) differential - Comprehensive Metabolic Panel ( Chemistry ) : bicarbonate , blood , urea , nitrogen ( BUN ) , calcium , creatinine , glucose , potassium , sodium - Liver Function Tests : Alkaline phosphatase ( ALP ) , Alanine transaminase ( ALT ) , Aspartate transaminase ( AST ) , total bilirubin - Carbohydrate antigen ( CA ) 19-9 ECGs conduct screen end treatment visit . CT scan chest abdomen do every 12 16 week . All data record store source document .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Signed Consent form Have adequate liver function Have adequate bone marrow function History allergy hypersensitivity human , humanize chimeric monoclonal antibody Any medical surgical condition may place subject increase risk treatment Uncontrolled intercurrent illness include , limited , ongoing active systemic infection , symptomatic congestive heart failure , unstable angina pectoris , clinically significant cardiac arrhythmia , psychiatric illness/social situation would limit compliance treatment requirement Current abuse alcohol drug</criteria>
	<gender>Female</gender>
	<minimum_age>83 Years</minimum_age>
	<maximum_age>83 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>